Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering Of Upto $1 Billion - SEC Filing
31/08/2023 23:10
MoonLake Immunotherapeutics MLTX.O :
* MOONLAKE IMMUNOTHERAPEUTICS FILES FOR MIXED SHELF OFFERING
OF
UPTO $1 BILLION - SEC FILING
Source text for Eikon: ID:
Further company coverage: MLTX.O
Recent news on MoonLake Immunotherapeutics
See all newsMoonLake jumps as AbbVie's weak skin drug data eases competition fears
Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering, Size Not Disclosed
MoonLake Immunotherapeutics reports results for the quarter ended June 30 - Earnings Summary
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial (updated)
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial